ID: ALA426566
Chembl Id: CHEMBL426566
PubChem CID: 44421339
Max Phase: Preclinical
Molecular Formula: C214H376N34O124
Molecular Weight: 5409.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCN(CCNC(=O)CCN(CCC(=O)NCCN(CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)CCN(CCC(=O)NCCN(CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)CCC(=O)NCCN(CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)CCC(=O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NCCNC(=O)COCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C214H376N34O124/c249-75-107-151(293)159(301)175(317)207(349-107)365-191-115(83-257)357-199(183(325)167(191)309)341-67-1-21-215-135(277)91-333-99-143(285)231-37-29-223-123(265)9-49-243(50-10-124(266)224-30-38-232-144(286)100-334-92-136(278)216-22-2-68-342-200-184(326)168(310)192(116(84-258)358-200)366-208-176(318)160(302)152(294)108(76-250)350-208)61-45-239-131(273)17-57-247(58-18-132(274)240-46-62-244(51-11-125(267)225-31-39-233-145(287)101-335-93-137(279)217-23-3-69-343-201-185(327)169(311)193(117(85-259)359-201)367-209-177(319)161(303)153(295)109(77-251)351-209)52-12-126(268)226-32-40-234-146(288)102-336-94-138(280)218-24-4-70-344-202-186(328)170(312)194(118(86-260)360-202)368-210-178(320)162(304)154(296)110(78-252)352-210)65-66-248(59-19-133(275)241-47-63-245(53-13-127(269)227-33-41-235-147(289)103-337-95-139(281)219-25-5-71-345-203-187(329)171(313)195(119(87-261)361-203)369-211-179(321)163(305)155(297)111(79-253)353-211)54-14-128(270)228-34-42-236-148(290)104-338-96-140(282)220-26-6-72-346-204-188(330)172(314)196(120(88-262)362-204)370-212-180(322)164(306)156(298)112(80-254)354-212)60-20-134(276)242-48-64-246(55-15-129(271)229-35-43-237-149(291)105-339-97-141(283)221-27-7-73-347-205-189(331)173(315)197(121(89-263)363-205)371-213-181(323)165(307)157(299)113(81-255)355-213)56-16-130(272)230-36-44-238-150(292)106-340-98-142(284)222-28-8-74-348-206-190(332)174(316)198(122(90-264)364-206)372-214-182(324)166(308)158(300)114(82-256)356-214/h107-122,151-214,249-264,293-332H,1-106H2,(H,215,277)(H,216,278)(H,217,279)(H,218,280)(H,219,281)(H,220,282)(H,221,283)(H,222,284)(H,223,265)(H,224,266)(H,225,267)(H,226,268)(H,227,269)(H,228,270)(H,229,271)(H,230,272)(H,231,285)(H,232,286)(H,233,287)(H,234,288)(H,235,289)(H,236,290)(H,237,291)(H,238,292)(H,239,273)(H,240,274)(H,241,275)(H,242,276)/t107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,151+,152+,153+,154+,155+,156+,157+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191+,192+,193+,194+,195+,196+,197+,198+,199-,200-,201-,202-,203-,204-,205-,206-,207-,208-,209-,210-,211-,212-,213-,214-/m1/s1
Standard InChI Key: MEZBWHJJMYCHMV-BAZIZFQDSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 5409.48 | Molecular Weight (Monoisotopic): 5406.4161 | AlogP: | #Rotatable Bonds: |
| Polar Surface Area: | Molecular Species: | HBA: | HBD: |
| #RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
| Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
| 1. Joosten JA, Loimaranta V, Appeldoorn CC, Haataja S, El Maate FA, Liskamp RM, Finne J, Pieters RJ.. (2004) Inhibition of Streptococcus suis adhesion by dendritic galabiose compounds at low nanomolar concentration., 47 (26): [PMID:15588085] [10.1021/jm049476+] |
Source(1):
